| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $226.4M | -72.4% |
| Cost of Revenue | $104.7M | -75.0% |
| Gross Profit | $408.1M | +1.8% |
| R&D Expense | $190.7M | -6.4% |
| SG&A Expense | $55.0M | +7.7% |
| Operating Income | -$24.3M | +49.7% |
| Pre-tax Income | -$55.4M | +50.8% |
| Income Tax | $10.8M | +174.6% |
| Net Income | -$66.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.6M | -60.3% |
| Accounts Receivable | $268.4M | +0.4% |
| Inventory | $77.5M | +2.8% |
| Current Assets | $418.7M | -12.4% |
| Total Assets | $1.14B | -8.9% |
| Current Liabilities | $341.1M | +3.2% |
| Long-term Debt | $235.4M | -28.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.1M | +164.8% |
| Capital Expenditures | $9.4M | -8.5% |
| Investing Cash Flow | -$9.5M | +21.9% |
| Financing Cash Flow | -$47.9M | -5240.6% |
| Free Cash Flow | $7.7M | +121.0% |
| +32.5% |
| EPS (Basic) | -$0.39 | +38.1% |
| EPS (Diluted) | -$0.39 | +38.1% |
| Total Liabilities |
| $691.4M |
| -6.2% |
| Stockholders' Equity | $452.8M | -12.7% |